What's Happening?
Countable Labs and Promega have announced a co-marketing agreement to combine their technologies for improved biological sample preparation and rare variant detection. The partnership integrates Promega's Maxwell System for nucleic acid extraction with
Countable Labs' Countable PCR technology, offering a comprehensive solution for DNA and RNA quantification. This collaboration aims to enhance the accuracy and efficiency of research in fields such as oncology and molecular diagnostics.
Why It's Important?
The partnership between Countable Labs and Promega represents a significant advancement in the field of biological research, providing scientists with a more efficient and accurate method for sample preparation and analysis. By combining their technologies, the companies aim to improve the detection of rare genetic variants, which is crucial for advancing research in areas like cancer diagnostics and personalized medicine. This collaboration could lead to more precise and reliable research outcomes, benefiting the scientific community and healthcare industry.
What's Next?
The companies plan to host a joint webinar to demonstrate the capabilities of their combined workflow and educate researchers on its applications. As the partnership progresses, Countable Labs and Promega may explore further collaborations to expand their offerings and address additional challenges in the life sciences industry. Researchers and industry stakeholders will be watching for updates on the impact of this partnership on scientific research and innovation.
